Semnur Pharmaceuticals, Inc. (SMNR)

Price & Market Data

Price: $5.99

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $1,378,952,704

Daily Volume: 0

Performance Metrics

1 Week: -4.92%

1 Month: -25.12%

3 Months: -25.12%

6 Months: -36.61%

1 Year: -70.05%

YTD: -29.53%

About Semnur Pharmaceuticals, Inc. (SMNR)

Market analysis of Semnur Pharmaceuticals, Inc. (SMNR). Current price: 5.99, daily change: $0.00 / 0.00%. Market cap: 1,378,952,704. All updated performance metrics available.

Company Details

Employees: 3

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Semnur Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate is SP-102, a novel viscous gel formulation of corticosteroid to treat lumbosacral radicular pain, or sciatica, which is in the second Phase 3 study. The company was founded in 2013 and is headquartered in Palo Alto, California. Semnur Pharmaceuticals, Inc. operates as a subsidiary of Scilex Holding Company.

Selected stocks

IA FINL CORP INC. (IAFNF)

Quantum Genesis AI Corp. (QGAI)

Spark Energy Minerals Inc. (SPARF)

Questcorp Mining Inc. (QQCMF)

PETROTECH OIL & GAS INC (PTOG)